CC
KURA icon

Corton Capital’s Kura Oncology KURA Stock Holding History

Corton Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$237K Sell
26,822
-8,259
-24% -$58.9K 0.58% 64
2025
Q2 		$202K Buy
35,081
+9,781
+39% +$59.9K 0.24% 237
2025
Q1 		$167K Buy
25,300
+13,956
+123% +$109K 0.55% 84
2024
Q4 		$98.8K Buy
+11,344
New +$163K 0.06% 351
2023
Q4 		– Sell
-18,409
Closed -$168K – 620
2023
Q3 		$168K Buy
18,409
+1,018
+6% +$10.3K 0.08% 336
2023
Q2 		$184K Buy
+17,391
New +$206K 0.09% 347
2022
Q3 		– Sell
-10,400
Closed -$191K – 324
2022
Q2 		$191K Sell
10,400
-1,685
-14% -$24.2K 0.18% 234
2022
Q1 		$194K Buy
+12,085
New +$175K 0.08% 362

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Corton Capital's KURA Position: Q3 2025 in Review

Corton Capital reduced its Kura Oncology (KURA) stake by 24% in Q3 2025, selling an estimated $58.9K and leaving 26,822 shares worth $237K. The position accounts for 0.58% of the portfolio, ranked #64.

Corton Capital first reported a position in KURA in Q1 2022 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Corton Capital held 26,822 shares of Kura Oncology worth $237K as of Q3 2025.
  • Corton Capital sold 8,259 Kura Oncology shares in Q3 2025, an estimated $58.9K.
  • Kura Oncology made up 0.58% of Corton Capital's portfolio in Q3 2025, its #64 holding.
  • Corton Capital first reported a position in Kura Oncology in Q1 2022 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.